Nys Hospitals Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 4.00 Cr
as on 17-12-2024
- Company Age 10 Months 22 Days
- Open Charges ₹ 10.90 Cr
as on 17-12-2024
About Nys Hospitals
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹10.90 Cr.
Sanjeev Sharma, Sahil Mahajan, Naresh Mahajan, and One other member serve as directors at the Company.
- CIN/LLPIN
U86100PB2024PTC060652
- Company No.
060652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nys Hospitals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Sharma  | Director | 02-Feb-2024 | Current |
| Sahil Mahajan | Director | 02-Feb-2024 | Current |
| Naresh Mahajan | Director | 02-Feb-2024 | Current |
| Yogesh Khanna | Director | 02-Feb-2024 | Current |
Financial Performance of Nys Hospitals.
Enhance accessibility to Nys Hospitals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nys Hospitals?
Unlock access to Nys Hospitals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ravenbhel Pharmaceuticals Private LimitedActive 24 years 12 daysSanjeev Sharma, Sahil Mahajan and 2 more are mutual person
Macmillon Pharmaceuticals Private LimitedActive 36 years 3 monthsSahil Mahajan and Naresh Mahajan are mutual person
Ravenmac Pharmaceuticals Private LimitedActive 14 years 9 monthsSahil Mahajan and Naresh Mahajan are mutual person
Salutemlab Formulations Private LimitedActive 1 year 2 monthsSahil Mahajan and Naresh Mahajan are mutual person
- Salutemlife Sciences Private LimitedActive 1 year 2 months
Sahil Mahajan and Naresh Mahajan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Feb 2024 | ₹9.70 Cr | Open |
Others Creation Date: 29 Feb 2024 | ₹1.20 Cr | Open |
How Many Employees Work at Nys Hospitals?
Unlock and access historical data on people associated with Nys Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nys Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nys Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.